Skip to content

biotechbrothers

Main navigation

Social Media Marketing
About
Careers
Let’s Connect
Biotech Connections

Category Archive: Inclisiran

The Flop of the Decade: A PCSK9 Inhibitor with a Price Tag of $14,100

The cardiovascular disease is a lucrative market for many pharmaceutical and biotechnology companies to break in. It is […]

January 18, 2020 biotech, Biotech Billionaire, Biotech Hub, Breaking In Biotech, Inclisiran, Novartis, Pharma, Repatha, siRNA

Novartis Acquires The Medicines Company for $9.7 Billion

A Global Switzerland Pharmaceutical, Novartis, has agreed to acquire Medicines Company (NASDAQ: MDCO) for a staggering $9.7 Billion. […]

November 26, 2019 acquisitions, Biology, Biopharma, Biopharmaceuticals, biotech, Biotech Billionaire, Biotech Hub, Breaking In Biotech, Buyout, Inclisiran, low-density lipoprotein (LDL), Medicine Co., Novartis, ow-density lipoprotein, Pcsk9, PCSK9 Inhibitor, Pharma, Science, siRNA, The Medicines Company

Powered by WordPress.com.

Home
Careers
Consultation
Products and Service
Social Media Management
About
Contact
Let’s Connect

Secondary navigation

Search

Search for:

Begin typing your search above and press return to search. Press Esc to cancel.